Skip links

Korea Signs Agreement with Astrazeneca for Covid Vaccine

Korea Signs Agreement with AstraZeneca for COVID Vaccine: What You Need to Know

South Korea has recently signed an agreement with AstraZeneca to acquire its COVID-19 vaccine. The deal will ensure that South Korea receives enough AstraZeneca vaccines to inoculate over 10 million people. The country`s health authorities have hailed the agreement as a significant milestone in Korea`s fight against the pandemic. The agreement comes as the country experiences a third wave of COVID-19 infections, with daily cases surpassing 1,000.

Here`s what you need to know about the deal:

1. The agreement will allow South Korea to receive about 10 million doses of the AstraZeneca vaccine, enough to vaccinate 5 million people.

2. The AstraZeneca vaccine is expected to be rolled out in South Korea in the second quarter of 2021, subject to regulatory approval.

3. The vaccine has been developed by AstraZeneca in partnership with the University of Oxford and is one of the most promising candidates in the race for a COVID-19 vaccine.

4. AstraZeneca has pledged to provide the vaccine on a non-profit basis during the pandemic and has been working with international partners to ensure that the vaccine is available globally.

5. South Korea has also signed agreements with other pharmaceutical companies, including Pfizer and Moderna, to acquire their COVID-19 vaccines. The country has also joined the global COVAX initiative, which aims to ensure equitable access to vaccines for all countries.

The agreement with AstraZeneca is a significant step forward in South Korea`s efforts to contain the spread of COVID-19. The country has been praised for its response to the pandemic, which has included widespread testing and contact tracing. However, with daily cases continuing to rise, the vaccine is seen as a key tool in the fight against the virus.

As the world waits for a COVID-19 vaccine, the agreement between South Korea and AstraZeneca highlights the importance of global collaboration in developing and distributing a vaccine. It also shows that countries must work together to ensure that vaccines are available to all, regardless of their ability to pay. Hopefully, the rollout of the AstraZeneca vaccine in South Korea will be a step towards ending the pandemic and returning to some semblance of normalcy.